Enhanced Genomics is a biotechnology company specializing in 3D multi-omics to identify genetically validated drug targets for complex genetic diseases. Utilizing a proprietary platform and cell type-specific atlas, the company translates disease-associated data into actionable insights, enhancing the probability of success in pharmaceutical development. Enhanced Genomics focuses on addressing unmet medical needs in common diseases, including autoimmune conditions, by developing effective therapies through strategic partnerships with pharma and biotech sectors.
Leadership & Board
Current Number of Employees15
Current LinkedIn Followers5,847
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$19M
Total Amount Raised$19M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$19M
Latest Funding Amount$19M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Enhanced Genomics had 15 employees as of June 29, 2026. The number of employees decreased by 1 (6.25%) week-over-week.
15Latest Employee Count
1(-6.25%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Enhanced Genomics had 5,847 followers as of June 29, 2026. The number of followers increased by 4 (0.07%) week-over-week.
5,847Latest Followers Count
4(0.07%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.